@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:show . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:52:10.568062"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "To date" . rdf:OBJECT-POSITION rdfs:label "3"^^xsd:integer . rdf:PREDICATE rdfs:label "shown" . rdf:PREDICATE-POSITION rdfs:label "[53]" . rdf:SUBJECT rdfs:label "only dexamethasone and remdesivir" . rdf:SUBJECT-POSITION rdfs:label "14"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "wu0iwj8x" . rdfs:SENTENCE rdfs:label "To date, only dexamethasone and remdesivir have been shown to be effective, but several other promising candidates are in trials." . rdfs:TRIPLE-UID ns3:wu0iwj8x-TRIPLE-ABSTRACT-1 "wu0iwj8x-TRIPLE-ABSTRACT-1" . rdfs:label "date" . rdfs:label "dexamethasone" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "MDDOYVxxbz2mVoVDJ1eyQCDLfWyAMqXsdbuNzCSidrKE7KQ7Ny/M1M+OERBAUnG1jx+c0txbql08mFiIxjKQR24dQHw08SzlWrPSlSlhwIaUH9LbjYnT97qzhSxmwftS+iv3o3Rbq7uRBSZnMgDUnvrooIS1OepqULjm0PyDcxI="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:52:10.568062"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }